Access cutting-edge breast cancer treatment through this clinical trial at a research site in Stamford. Study-provided care at no cost to qualified participants.
Access breast cancer specialists in Stamford at no cost
This study follows strict safety protocols and ethical guidelines
All study-related breast cancer treatment provided free
This research study is studying a combination of HER2-directed therapies (trastuzumab and pertuzumab) and hormonal therapy as a treatment after surgery for hormone receptor positive breast cancer. The study drugs involved in this study are: * A combination of trastuzumab and pertuzumab given as an injection under the skin (PHESGO) * Hormonal (endocrine) Treatment
Sponsor: Dana-Farber Cancer Institute
Check if you qualify for this breast cancer clinical trial in Stamford, CT
If you're searching for breast cancer treatment options in Stamford, CT, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Stamford research site is actively enrolling participants for this clinical trial. You'll receive care from experienced breast cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.